Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17826-33-4

Post Buying Request

17826-33-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17826-33-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 17826-33-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,8,2 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 17826-33:
(7*1)+(6*7)+(5*8)+(4*2)+(3*6)+(2*3)+(1*3)=124
124 % 10 = 4
So 17826-33-4 is a valid CAS Registry Number.

17826-33-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(3,4-dichlorophenyl)-2-ethylguanidine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17826-33-4 SDS

17826-33-4Relevant articles and documents

New imidazolidinedione derivatives as antimalarial agents

Zhang, Liang,Sathunuru, Ramadas,Luong, Thulan,Melendez, Victor,Kozar, Michael P.,Lin, Ai J.

experimental part, p. 1541 - 1549 (2011/03/23)

A series of new N-alky- and N-alkoxy-imidazolidinediones was prepared and assessed for prophylactic and radical curative activities in mouse and Rhesus monkey models. New compounds are generally metabolically stable, weakly active in vitro against Plasmodium falciparum clones (D6 and W2) and in mice infected with Plasmodium berghei sporozoites. Representative compounds 8e and 9c showed good causal prophylactic activity in Rhesus monkeys dosed 30 mg/kg/day for 3 consecutive days by IM, delayed patency for 19-21 days and 54-86 days, respectively, as compared to the untreated control. By oral, 9c showed only marginal activity in causal prophylactic and radical curative tests at 50 mg/kg/day × 3 and 30 mg/kg/day × 7 plus chloroquine 10 mg/kg for 7 days, respectively.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17826-33-4